Country
Drug factories in South Korea
10 plants in South Korea are named on current U.S. prescription drug labels. FDA has inspected 9 of them; 2 had serious problems at their last inspection.
| Plant | City | Products | Last FDA inspection |
|---|---|---|---|
| Samsung Biologics Co., Ltd. | Incheon | 15 | Problems found, fixed voluntarilySep 2023 |
| Huons Co., Ltd. | Jecheon-si | 14 | Serious problems, FDA actionNov 2025 |
| Yuhan Chemical Inc. | Ansan-si | 8 | Problems found, fixed voluntarilyFeb 2025 |
| Hugel, Inc. | Chuncheon-si | 2 | Problems found, fixed voluntarilyOct 2023 |
| CELLTRION Inc | Incheon | 1 | Problems found, fixed voluntarilyMay 2024 |
| Celltrion Pharm, Inc | Cheongju | 1 | Problems found, fixed voluntarilyJul 2024 |
| GC Biopharma Corp Ochang Plant | Cheongju | 1 | Not inspected on record |
| ST Pharm Co., Ltd. | Ansan | 1 | Problems found, fixed voluntarilyJul 2023 |
| Sam Chun Dang Pharm Co, Ltd | Hwaseong | 1 | Serious problems, FDA actionMay 2026 |
| Taejoon Pharmaceutical Co., Ltd. | Yongin-si | 1 | Problems found, fixed voluntarilyOct 2022 |